Figure 4
From: Binding of doxorubicin to Sorcin impairs cell death and increases drug resistance in cancer cells
Sorcin expression versus cell death. (top) Western blot experiment showing the expression of Sorcin in lung carcinoma Calu-1, A459 and H1299 cells; cervix adenocarcinoma HeLa; breast adenocarcinoma MDA-MB-468 and MDA-MB-231. (bottom) Cell death is increased upon 24 h doxorubicin (0.6 μM) treatment in A549 and HeLa cells, where Sorcin expression level is reduced by >80% with respect to H1299 cells
